drugset / Trial / NCT07807059
A Single-Dose Pharmacokinetic Study of HRS-4729 Injection in Healthy Participants and Patients With Renal Impairment
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This study aims to evaluate the pharmacokinetic effects of a single dose of HRS-4729 injection in participants with mild, moderate, and severe renal impairment, with 8 participants enrolled in each renal impairment group and 8 healthy participants.
Timeline
- Start
- 2026-09-09
- Primary completion
- 2027-03-15
- Completion
- 2027-03-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HRS-4729 | Unknown | — | Subcutaneous |